Market Access Policy in Focus: Unpacking GLOBE, GUARD, and TrumpRx with Al... Unpack the impact of Most-Favoured Nations in GLOBE and GUARD pricing models, and TrumpRx, with Alice Valder Curran's clear policy overview.
News CMS's Medicare price negotiations start round three The US federal government has named the next 15 big-selling medicines that will be subject to Medicare pricing negotiations.
News Trump raises spectre of drug pricing mandates for Medicare CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.
Digital Harnessing AI to make Medicare more efficient, fair, and pat... As part of “WISeR” requirements, CMS selected tech vendors to implement enhanced technological models to scrutinise claims involving those on Medicare
News Latest Medicare pricing cuts promise $12bn in savings The CMS has revealed the prices for the second batch of 15 drugs going through Medicare's negotiation process, promising net savings of 44% on 2024.
News AZ takes Medicare negotiation appeal to SCOTUS AstraZeneca has elevated its challenge to Medicare drug price negotiation powers to the Supreme Court of the US.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.